Number of the records: 1  

The role of Her2 and other oncogenes of the PI3K/AKT pathway in mitochondria

  1. 1.
    SYSNO ASEP0465807
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleThe role of Her2 and other oncogenes of the PI3K/AKT pathway in mitochondria
    Author(s) Rohlenová, Kateřina (BTO-N) ORCID, RID
    Neužil, Jiří (BTO-N) RID
    Rohlena, Jakub (BTO-N) RID, ORCID
    Number of authors3
    Source TitleBiological Chemistry. - : Walter de Gruyter - ISSN 1431-6730
    Roč. 397, č. 7 (2016), s. 607-615
    Number of pages9 s.
    Languageeng - English
    CountryDE - Germany
    Keywordsalpha-tocopheryl succinate ; mitochondria ; oxidase subunit-ii ; protein-kinase b
    Subject RIVEB - Genetics ; Molecular Biology
    R&D ProjectsED1.1.00/02.0109 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    Institutional supportBTO-N - RVO:86652036
    UT WOS000377892600004
    DOI10.1515/hsz-2016-0130
    AnnotationAltered metabolism and resistance to cell death are typical hallmarks of cancer phenotype. Mitochondria are organelles central to cellular metabolism as well as to cell death induction. Hyperactivation of pro-survival and pro-proliferative pathways such as PI3K/AKT leads to cancer initiation, which affects mitochondria. Growing body of evidence indicates that oncogenes such as HER2, EGFR and RAS, as well as the downstream members of the PI3K/AKT signaling pathway, directly regulate mitochondria by translocating to the organelle. Here we discuss evidence of this scenario and consider mechanisms for direct regulation of mitochondrial function. Being in close proximity to mitochondrial bioenergetics machinery as well as to the regulators/executors of programed cell death, oncogenes in mitochondria may be ideally placed to perform this task. This represents a thus far under-explored area, which may be relevant to better understanding of cancer initiation, progression and treatment.
    WorkplaceInstitute of Biotechnology
    ContactMonika Kopřivová, Monika.Koprivova@ibt.cas.cz, Tel.: 325 873 700
    Year of Publishing2017
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.